James R Meyers - Net Worth and Insider Trading
James R Meyers Net Worth
The estimated net worth of James R Meyers is at least $198,874 dollars as of 2024-03-28. James R Meyers is the EVP Worldwide Commercial Ops of Gilead Sciences Inc and owns about 2,715 shares of Gilead Sciences Inc (GILD) stock worth over $198,874. Details can be seen in James R Meyers's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that James R Meyers has not made any transactions after 2018-01-16 and currently still holds the listed stock(s).
Transaction Summary of James R Meyers
James R Meyers Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, James R Meyers owns 4 companies in total, including CytomX Therapeutics Inc () , Arbutus Biopharma Corp () , and Sangamo Therapeutics Inc () among others .
Click here to see the complete history of James R Meyers’s form 4 insider trades.
Insider Ownership Summary of James R Meyers
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
CytomX Therapeutics Inc | 2018-12-20 | director | |
Arbutus Biopharma Corp | 2019-08-17 | director | |
Sangamo Therapeutics Inc | 2019-11-22 | director | |
Gilead Sciences Inc | 2018-01-16 | EVP Worldwide Commercial Ops |
James R Meyers Latest Holdings Summary
James R Meyers currently owns a total of 1 stock. James R Meyers owns 2,715 shares of Gilead Sciences Inc (GILD) as of January 16, 2018, with a value of $198,874.
Latest Holdings of James R Meyers
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
GILD | Gilead Sciences Inc | 2018-01-16 | 2,715 | 73.25 | 198,874 |
Holding Weightings of James R Meyers
James R Meyers Form 4 Trading Tracker
According to the SEC Form 4 filings, James R Meyers has made a total of 0 transactions in Gilead Sciences Inc (GILD) over the past 5 years. The most-recent trade in Gilead Sciences Inc is the sale of 100,000 shares on January 16, 2018, which brought James R Meyers around $8 Million.
Insider Trading History of James R Meyers
- 1
James R Meyers Trading Performance
James R Meyers Ownership Network
Ownership Network List of James R Meyers
Ownership Network Relation of James R Meyers
James R Meyers Owned Company Details
What does CytomX Therapeutics Inc do?
Who are the key executives at CytomX Therapeutics Inc?
James R Meyers is the director of CytomX Therapeutics Inc. Other key executives at CytomX Therapeutics Inc include SVP & Chief Scientific Officer Marcia Belvin , SVP & Finance and Accounting Christopher Ogden , and Chief Financial Officer Jeffrey B Landau .
CytomX Therapeutics Inc () Insider Trades Summary
Over the past 18 months, James R Meyers made no insider transaction in CytomX Therapeutics Inc (). Other recent insider transactions involving CytomX Therapeutics Inc () include a net sale of 55,496 shares made by Sean A. Mccarthy , a net sale of 16,868 shares made by Lloyd A Rowland , and a net sale of 16,235 shares made by Jeffrey B Landau .
In summary, during the past 3 months, insiders sold 47,819 shares of CytomX Therapeutics Inc () in total and bought 0 shares, with a net sale of 47,819 shares. During the past 18 months, 121,072 shares of CytomX Therapeutics Inc () were sold and 5,000 shares were bought by its insiders, resulting in a net sale of 116,072 shares.
CytomX Therapeutics Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.
CytomX Therapeutics Inc Insider Transactions
James R Meyers Mailing Address
Above is the net worth, insider trading, and ownership report for James R Meyers. You might contact James R Meyers via mailing address: Gilead Sciences, Inc., 333 Lakeside Drive, Foster City Ca 94404.